Achieve Life Sciences, Inc.

Thank you. Thank you. Thank you. Good afternoon, ladies and gentlemen, and welcome to the Achieve Life Scientist Third Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. If anyone should require assistance during the conference, please press star then zero on your touchstone telephone. As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host. Executive Vice President of Commercial at Achieve Life Sciences, Ms. Jane Azenas. Ma'am, the floor is yours.

Thank you, Laura, and thanks, everyone, for joining us. On the call today from Achieve, we have John Bensich, Chief Executive Officer, Dr. Cindy Jacobs, President and Chief Medical Officer, Jerry Wan, Principal Accounting Officer, Rick Stewart, Executive Chairman of the Board of Directors, and Dr. Anthony Clark, Chief Scientific Officer. I'd like to remind everyone that today's conference call contains forward-looking statements based on current expectations. These statements are only predictions and actual results may vary materially from those projected. Please refer to Achieve documents filed with the SEC concerning factors that could affect the company, copies of which are available on our website. I'll now turn the call over to John.

Thank you, Jamie. We've certainly had a very busy and exciting third quarter. On today's call, we will discuss recently announced changes to our management team, details of our Phase III ORCA II trial that we initiated last month, a review of data presented at the Society for Research on Nicotine and Tobacco European meeting, including results from the RAURA head-to-head study of cytosine and clean versus Chantix, and finally, order financial results. To begin, at the end of September, we announced that I would be transitioning from Chief Financial and Operating Officer into the role of CEO. the role of CEO. Rick Stewart, Achieve's co-founder and former CEO, is continuing to serve as our executive chairman of the board of directors and remains actively involved in the company's strategic operations. Additionally, we announced that Dr. Cindy Jacobs, Achieve's chief medical officer, will assume the role of president, previously held by Dr. Anthony Clark. Dr. Clark, also a co-founder of Achieve, will continue to serve as our chief scientific officer. And finally, Jerry Wan, former Senior Director of Accounting Operations, has been promoted to the position of Principal Accounting Officer. While these changes were planned for some time, they were expedited in part by the pandemic, which has restricted international travel for Rick and Tony, who are both based in the UK. While our leadership structure has realigned, our management team remains dedicated in our mission and in our conviction that cytosinicline has great promise to change the lives of millions of smokers. To that end, I'd like to hand the call over to Cindy to discuss perhaps the most compelling highlight of the quarter, initiation of our Phase III ORCA II clinical trial. Cindy?